MIRA INFORM REPORT

 

 

Report Date :

17.02.2011

 

IDENTIFICATION DETAILS

 

Name :

ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD.

 

 

Registered Office :

No. 99 Waisha Road, Jiaojiang District, Taizhou, Zhejiang Province, 318000 Pr

 

 

Country :

China

 

 

Financials (as on) :

31.12.2009

 

 

Date of Incorporation :

13.07.1998

 

 

Com. Reg. No.:

330000000014592

 

 

Legal Form :

Shares Limited Company

 

 

Line of Business :

Manufacturing and Selling Chemical Raw Materials.

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 1,500,000

Status :

Satisfactory 

Payment Behaviour :

No Complaints

Litigation :

Clear

 


 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – June 30, 2010

 

Country Name

Previous Rating

                   (01.04.2010)                  

Current Rating

(30.06.2010)

China

a2

a2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

Company name & address

 

zhejiang jiuzhou pharmaceutical co., ltd.

no. 99 waisha road, jiaojiang district, taizhou,

zhejiang PROVINCE, 318000 PR CHINA

99

TEL: 86 (0) 576-88827517           FAX: 86 (0) 576-8881998

 

 

EXECUTIVE SUMMARY

 

INCORPORATION DATE            : JULY 13, 1998

REGISTRATION NO.                  : 330000000014592

REGISTERED LEGAL FORM     : SHARES LIMITED CO.

CHIEF EXECUTIVE                   : MR. HUA XUANDE (CHAIRMAN)

STAFF STRENGTH                    : 1,500

REGISTERED CAPITAL             : CNY 74,200,000

BUSINESS LINE                        : MANUFACTURING

TURNOVER                              : CNY 647,366,000 (AS OF DEC. 31, 2009)

EQUITIES                                 : CNY 216,463,000 (AS OF DEC. 31, 2009)

PAYMENT                                : AVERAGE

RECOMM. CREDIT RANGE       : UP TO USD 1,500,000 (PERIODICAL REVIEW)

MARKET CONDITION                : COMPETITIVE

FINANCIAL CONDITION             : FAIRLY STABLE

OPERATIONAL TREND              : STEADY

GENERAL REPUTATION           : WELL-KNOWN

EXCHANGE RATE                     : CNY 6.66 = USD 1 

 

 

Adopted abbreviations

 

ANS - amount not stated           

NS - not stated 

SC - subject company (the company inquired by you)

NA - not available          

CNY - China Yuan Renminbi

 

 

 


 

Rounded Rectangle: HISTORY 

 

 


SC was registered as a Shares limited co. at local Administration for Industry & Commerce (AIC - The official body of issuing and renewing business license) on July 13, 1998.

 

Company Status:  Shares limited co.

This form of business in PR China is defined as a legal person. Its registered capital is divided into shares of equal par value and the co. raises capital by issuing share certificates by promotion or by public offer. Shareholders bear limited liability to the extent of shareholding, and the co. is liable for its debts only to the extent of its total assets. The co has independent property of legal person and enjoys property rights of legal person. The characteristics of the shares limited co. are as follows:

The establishment of the co. requires at least two promoters and no more than 200, half of whom shall be domiciled in China.. Natural person are allowed to serve as promoters.

The minimum registered capital of a co. is CNY 5M. while that of the co. with foreign investment is CNY 5M. The total capital of a co. which propose to apply for publicly listed must be no less than CNY 30M.

The board of directors must consist of five to nineteen directors.

If the co. raises capital by public offer, the promoters must not subscribe less than 35% of the total shares. the promoters’ shares are restricted to transfer- within one year of the offer.

A state-owned enterprise that is restructured into a shares limited co. must comply with the conditions & requirements specified under the law & administrative rule.

 

 

 

 

 

 

 

 

 

 

 

                                                

 

 

 

 

 

 

 

 

SC’s registered business scope includes manufacturing and selling chemical raw materials, pharmaceutical intermediates, chemical materials (excluding precursor chemicals and other dangerous articles), mechanical equipment, instruments and meters; research and development of  medicine and chemical products, technical consulting services, importing and exporting business.

 

SC is mainly engaged in manufacturing and selling chemical raw materials.

 

Mr. Hua Xuande has been legal representative and chairman of SC since 1998.

 

SC is known to have approx. 1,500 employees at present.

 

SC is currently operating at the above stated address, and this address houses its operating office and factory in the industrial zone of Taizhou. Our checks reveal that SC owns the total premise about 200,000 square meters.

 


Rounded Rectangle: WEB SITE

 


http://www.jiuzhou-pharma.com The design is professional and the content is well organized. At present it is both in Chinese and English versions.

 

E-Mail: zboffice@zbjz.cn

 

 

Rounded Rectangle: KEY EVENTS/RECENT DEVELOPMENT 

 

 


Date of change

Item

Before the change

After the change

2002-01-24

Shareholders

Taizhou Yizhou Chemical Industry Co., Ltd.(1.89%), Zhejiang Huangyan 9th Chemical Plant(3.77%), Taizhou Jiaojiang Siwei Chemical Plant(1.89%), Hainan Qiongshan Wangda Trade Co., Ltd.(5.66%), Zhejiang Zhongbei Jiuzhou Group Limited(86.79%)

Taizhou Yizhou Chemical Industry Co., Ltd.(1.89%), Zhejiang Huangyan 9th Chemical Plant(3.77%), Taizhou Jiaojiang Siwei Chemical Plant(1.89%), Hua Lirong(5.66%), Zhejiang Zhongbei Jiuzhou Group Limited(86.79%)

 2007-12-24

Shareholders

(Shareholding)

Taizhou Yizhou Chemical Industry Co., Ltd.(1.89%), Zhejiang Huangyan 9th Chemical Plant (3.77%), Taizhou Jiaojiang Siwei Chemical Plant(1.89%), Hua Lirong(5.66%), Zhejiang Zhongbei Jiuzhou Group Limited(86.79%)

Taizhou Siwei Chemical Plant(1.89%), Zhejiang Yizhou Chemical Industry Co., Ltd.(1.89%), Zhejiang Oma Pharmaceutical Co., Ltd.(3.77%), Hua Lirong(5.66%), Zhejiang Zhongbei Jiuzhou Group Limited (86.79%)

Registered no.

3300001001670

330000000014592

2008-12-17

Registered capital

CNY 26,500,000

Present amount

Shareholders

(Shareholding)

Taizhou Siwei Chemical Plant(1.89%), Zhejiang Yizhou Chemical Industry Co., Ltd.(1.89%), Zhejiang OMA PHARMACEUTICAL CO.,Ltd.(3.77%), Hua Lirong(5.66%), Zhejiang Zhongbei Jiuzhou Group Limited(86.79%)

Present ones

 

SC has passed ISO9001, ISO9002 and SFDA'S (State Food and Drug Administration) GMP Inspection.

 

 

Rounded Rectangle: OWNERSHIP/MANAGEMENT BACKGROUND 

 

 


MAIN SHAREHOLDERS:

 
Name                                                                                      % of Shareholding

 

Zhejiang Zhongbei Jiuzhou Group Limited                                                88.11

 

Zhejiang Oma Pharmaceutical Co., Ltd.                                                     3.77

 

Taizhou Siwei Investment Co., Ltd.                                                          2.45

 

Hua Lirong                                                                                             5.67

 

 

Zhejiang Zhongbei Jiuzhou Group Limited

===============================

Add: No. 99 Waisha Road, Taizhou.

Tel: 0576-88827580

 

Zhejiang Oma Pharmaceutical Co., Ltd.

============================

Oma is a pharmaceutical & chemical enterprise specializing in producing pharmaceutical intermediates and APIs, with self-support import and export authority. Oma received ISO9001 Quality System Certification in 2000; and it became an ISO14000 approved company in 2005.

Add.: Xiayanggu, Huangyan, Taizhou City, Zhejiang Province, China

Zip code: 318020

Tel: +86-576-84058058, 84058028, 84058168

Fax: +86-576-84058088

E-mail: sales@omapharm.com

URL: http://www.omapharm.com


 

Taizhou Siwei Investment Co., Ltd.

==========================

Add: No. 99 Waisha Road, Taizhou.

Tel: 0576-88827133

 

 

Rounded Rectangle: MANAGEMENT 

 

 


l         Chairman and General manager:

Mr. Hua Xuande (轩德) ID# 332601431030371, about 67 years old, with university education. He is currently responsible for the overall management of SC.

 

Working Experience(s):

 

From 1998 to present                 Working in SC as chairman and general manager;

Also working in Zhejiang Zhongbei Jiuzhou Group Limited as legal representative.

 

 

l         Vice-general manager:

Ms. Hua Lirong, ID# 460021196806162629, born in 1968. He is currently responsible for the daily management of SC.

 

Working Experience(s):

 

At present                     Working in SC as vice-general manager.

 

 

Rounded Rectangle: BUSINESS OPERATIONS
 BACKGROUND
 

 

 


SC is mainly engaged in manufacturing and selling chemical raw materials.

 

SC’s products mainly include: central nervous system, antibacterial, quinolone, antiparasitics agents, hypolycemic agents, antifungal agents and prostate agents.

 

 

SC sources its materials 90% from domestic market and 10% from the overseas market. SC sells 40% of its products to overseas market and 60% in domestic market.

 

The buying terms of SC include Check, L/C, T/T and Credit of 30-60 days. The payment terms of SC include Check, T/T, L/C, and Credit of 30-60 days.

 

 

 


 

Rounded Rectangle: RELATED COMPANIES

 BACKGROUND
 

 

 


SC is known to invest in the following companies:

 

Shanghai Zhongzhou Natural Drug Science and Technology Development Co., Ltd.

Investment Capital: CNY 450,000

Registration number: 3101101022422

 

Taizhou Jiaojiang Industrial Waste Disposal Co., Ltd.

Investment Capital: CNY 200,000

Registration number: 3310021005670

 

Zhejiang Jiuzhou Pharmaceutical Science & Technology Co., Ltd.

Investment Capital: CNY 5,000,000

Registration number: 330000000045814

 

Haining Sanlian Chemical Co., Ltd.

Investment Capital: CNY 1,530,000

Registration number: 330481000021311

 

Zhejiang Zhongbei Chemical Co., Ltd.

Investment Capital: CNY 20,000,000

Registration number: 331002000007154

 

Zhejiang Zhongbei Jiuzhou Imp. & Exp. Co., Ltd.

Investment Capital: CNY 15,000,000

Registration number: 331002000008180

 

Taizhou Siwei Chemical Co., Ltd.

Investment Capital: CNY 15,000,000

Registration number: 331002000008180

 

 

Rounded Rectangle: PAYMENT

 BACKGROUND
 

 

 


Overall payment appraisal:

(  ) Excellent      (  ) Good      (X) Average      (  ) Fair      (  ) Poor      (  ) Not yet determined

The appraisal serves as a reference to reveal SC's payments habits and ability to pay.  It is based on the 3 weighed factors:  Trade payment experience (through current enquiry with SC's suppliers), our delinquent payment and our debt collection record concerning SC.

 

Trade payment experience: SC did not provide any name of trade/service suppliers and we have no other sources to conduct the enquiry at present.

 

Delinquent payment record:   None in our database.

 

Debt collection record: No overdue amount owed by SC was placed to us for collection within the last 6 years.

 

Rounded Rectangle: BANKING

 BACKGROUND
 

 

 


Agriculture Bank of China Taizhou Jiaojiang Sub-branch

 

AC# 910101040010576

 

Relationship: Normal.

 

 

Rounded Rectangle: FINANCIAL HIGHLIGHTS

 BACKGROUND
 

 

 


Balance Sheet

Unit: CNY’000

 

as of Dec. 31, 2008

as of Dec. 31, 2009

Cash & bank

87,069

59,007

Bills receivable

1,622

6,732

Accounts receivable

60,385

83,306

Other receivables

7,512

1,685

Advances to suppliers

24,888

11,798

Inventory

114,990

128,877

Prepaid expenses

0

0

Other current assets

0

0

 

------------------

------------------

Current assets

296,466

291,405

Fixed assets net value

117,253

128,339

Projects under construction

31,600

37,456

Project materials

12,891

12,907

Long term investment

62,486

67,717

Other assets

46,004

49,483

 

------------------

------------------

Total assets

566,700

587,307

 

=============

=============

Short loans

185,500

162,793

Transactional Moneytary Liabilities

4,233

0

Bills payable

70,000

73,300

Accounts payable

70,313

93,471

Advances from clients

3,286

2,586

Salaries payable

7,584

11,158

Tax payable

4,286

3,869

Interest payable

346

259

Dividends payable

8,925

0

Other payable

23,240

7,408

Long-term liabilities due with in one year

15,000

16,000

Other current liabilities

0

0

 

------------------

------------------

Current liabilities

392,713

370,844

Long-term loans

16,000

0

 

------------------

------------------

Total liabilities

408,713

370,844

Equities

157,987

216,463

 

------------------

------------------

Total liabilities & equities

566,700

587,307

 

=============

=============

 

 

Income Statement

Unit: CNY’000

 

as of Dec. 31, 2008

as of Dec. 31, 2009

Turnover

792,520

647,366

Cost of goods sold

676,685

493,997

     Sales expense

10,505

7,496

     Management expense

49,586

67,734

     Finance expense

19,210

9,995

Profit before tax

34,696

68,536

Less: profit tax

2,267

10,220

Profits

32,429

58,316

 

 

Important Ratios

=============

 

as of Dec. 31, 2008

as of Dec. 31, 2009

*Current ratio

0.75

0.79

*Quick ratio

0.46

0.44

*Liabilities to assets

0.72

0.63

*Net profit margin (%)

4.09

9.01

*Return on total assets (%)

5.72

9.93

*Inventory /Turnover ×365

53 days

73 days

*Accounts receivable/Turnover ×365

28 days

47 days

*Turnover/Total assets

1.40

1.10

* Cost of goods sold/Turnover

0.85

0.76

 

 

Rounded Rectangle: FINANCIAL COMMENTS

 BACKGROUND
 

 

 


PROFITABILITY: FAIRLY GOOD

l         The turnover of SC appears fairly good in its line, but it decreased in 2009.

l         SC’s net profit margin is fairly good, and it increased in 2009.

l         SC’s return on total assets is fairly good, and it increased in 2009.

l         SC’s cost of goods sold is average, comparing with its turnover.

 

LIQUIDITY: FAIR

l         The current ratio of SC is maintained in a fair level.

l         SC’s quick ratio is maintained in a fair level.

l         The inventory conversion period of SC appears long.

l         The accounts receivable of SC appears average.

l         SC’s short-term loan is in a large.

l         SC’s turnover is in an average level, comparing with the size of its total assets.

 

 

LEVERAGE: AVERAGE

l         The debt ratio of SC is average in 2009.

l         The risk for SC to go bankrupt is average.

 

Overall financial condition of the SC: Fairly Stable.

 

 

Rounded Rectangle: REMARKS

 BACKGROUND
 

 

 


SC is considered large-sized in its line with fairly stable financial conditions. The large amount of inventory and short loans could be a threat to SC’s financial condition. A credit line up to USD 1,500,000 would appear to be within SC’s capacities upon a periodical review basis.

 

 


FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.45.45

UK Pound

1

Rs.72.91

Euro

1

Rs.61.43

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.